RecruitingPhase 3NCT06570889
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma (VICTORY)
Sponsor
Professor Klaus Bønnelykke
Enrollment
2,000 participants
Start Date
Dec 20, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The overall aim of the study is to develop a nutritional preventive vitamin D supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that supplementation in higher doses than recommended could reduce the risk of disease development.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years
Inclusion Criteria4
- Pregnant Danish women before week 26 with blood levels of EPA+DHA above 4.7% of total fatty acids
- No current vitamin D intake above the recommended 400 IU/day
- No endocrine-, heart-, kidney- or auto-immune disorders
- No disorders requiring treatment with blood thinning medication
Interventions
DIETARY_SUPPLEMENTCholecalciferol D3
Oral intake of 1 capsule per day from week 22-26 in pregnancy to 1 week after delivery
OTHEROlive oil
Oral intake of 1 capsule per day from week 22-26 in pregnancy to 1 week after delivery
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06570889
Related Trials
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
NCT06664619138 locations
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
NCT06052267393 locations
Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma
NCT047069881 location
To Assess the Management of Patients on Global Initiative of Asthma (GINA) Step 4 and 5 Treatment in Hong Kong
NCT046397911 location
Use of Biologics for Severe Asthma in Hong Kong
NCT067787461 location